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Background: Thrombus aspiration (TA) before stenting of the infarcted related artery has beneficial impact on myocardial reperfusion and clinical 
outcome in randomised controlled trials. This study evaluated the effect of thrombus aspiration in a real world STEMI population.
Methods: The decision to use TA was at the discretion of the treating cardiologist. The primary endpoint was residual ST deviation* (ST res) on the 
1 hour post PCI ECG (core-lab analysis). Secondary endpoints were post PCI TIMI flow, infarct size and 30 day mortality.
Results: Between 1 January 2006 and 31 December 2009 3216 pts presented with STEMI of which TA- and ECG data were available in 2457 pts 
(76%). No differences in baseline characteristics were present between the years, except for a significant increase in the use of TA and pre-hospitally 
administered 2b/3a blockers. The use of TA increased from 2% in 2006 to 43% in 2009 (p<0.001). Final TIMI 3 flow, ST res, infarct size and 30 day 
mortality did not improve over the years. Multivariate analysis showed that age (OR 1.01, 95%CI 1.00-1.01), infarct location (OR 2.6, 95% CI 2.2-
3.1), higher Killip class (OR 1.9, 95% CI 1.3-2.8) and the use of TA (OR 1.3, 95% CI 1.1-1.6), were independent predictors of high ST res (>3mm), 
whereas pre-hospital use of 2b/3a blockers (OR 0.7, 95% CI 0.6-0.9) was independently associated with low ST res (<3mm).
Conclusions: This study shows that the use of TA increased over time but was not associated with improved outcome in daily practice in a high 
volume STEMI center.
Characteristics 2006 N=585 2007 N=710 2008 N=571 2009 N=591 P
Thrombus aspiration 2% 6% 30% 43% <0.001
Pre-hospital GP IIb/IIIa inhibitor use 29% 30% 30% 53% <0.001
Final TIMI 3 flow 93% 93% 93% 96% 0.801
Residual ST-deviation 1 hr post PCI (mm±SD) 5.2±5.7 5.0±6.1 4.7±5.3 5.1±6.0 0.191
Enzymatic infarct size 28% 24% 24% 25% 0.33
Mortality 30 days 1.9% 2.8% 2.8% 3.8% 0.297
